Olson v. Novo Nordisk A/S et al
| Jarred Olson |
| Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk US Holdings Inc, Novo Nordisk US Commercial Holdings Inc, Novo Nordisk Inc, Novo Nordisk Research Center Seattle Inc and Novo Nordisk Pharmaceutical Industries LP |
| 2:2023cv00844 |
| November 16, 2023 |
| US District Court for the District of Utah |
| David Barlow |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 Diversity-Product Liability |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 19, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 5 NOTICE OF FILING of MDL Filings in MDL Case No. 3094 IN RE: Clucagon-like Peptide-1 Receptor Agonists: Watral Notice of Appearance, Schedule of Actions for D. Watral, Lilly Corporate Disclosure Statement, Schedule of Actions for Lilly Corp., Joint Motion for Extension of Time to Respond, Schedule of Actions fro Joint Motion, Proof of Service fo Joint Motion, Minute Order Granting In Part Motion for Extension, Proof of Service re D. Watral Notice of Appearance, Proof of Service re Lilly Corporate. Filings were emailed to the clerk by the the paralegal for Kirkland & Ellis LLP. (jwt) |
| Filing 4 NOTICE of Motion for Transfer of Actions to the United States District Court for the Western District of Louisiana and supporting documents filed by Jarred Olson in JPML pending case number 38 IN RE: GLP-1 Receptor Agonist Cases. (NOTE: the documents were sent to the Clerk's Office by email with a link to download the exhibits. The exhibits were not downloaded for inclusion with this entry but may be viewed in the originating court's docket.) (Attachments: #1 Memorandum in Support of Motion for Transfer of Actions, #2 Schedule of Actions, #3 Reasons Why Oral Argument Should Be Heard, #4 Exhibit List, #5 Proof of Service) (jwt) |
| Filing 3 NOTICE OF MAGISTRATE JUDGE AVAILABILITY TO PRESIDE OVER CASE- Under 28 U.S.C. 636(c), Fed. R. Civ. P. 73, and DUCivR 72-4, you are hereby notified that a magistrate judge for the District of Utah may conduct any or all proceedings in this case, including a jury or bench trial and entry of a final judgment. Exercise of this jurisdiction by the magistrate judge is permitted only if all parties voluntarily sign and return the form. To consent, return the Consent Form to the clerk's office within 21 days via email at consents@utd.uscourts.gov or mail at the address on the form. Please do not efile the Consent Form in the case. Notice e-mailed or mailed to Plaintiff Jarred Olson. (Notice generated by Clerk's office) Form due by 12/7/2023. (kec) |
| Filing 2 NOTICE OF REQUIREMENTS for appearance Pro Hac Vice mailed to attorney Paul Pennock and Jonathan M. Sedgh for Jarred Olson. (kec) |
| Filing 1 COMPLAINT against Novo Nordisk A/S, Novo Nordisk Inc, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries LP, Novo Nordisk Research Center Seattle Inc, Novo Nordisk US Commercial Holdings Inc, Novo Nordisk US Holdings Inc (Filing fee $ 402, receipt number AUTDC-4878807) filed by Jarred Olson. (Attachments: #1 Civil Cover Sheet) (Galvez, Justin) |
| Judge David Barlow added. Case number will now read 2:23-cv-00844-DBB. Please make changes to document captions accordingly. (kec) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Utah District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
